Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 427 publications
Effects of Evolocumab on Mortality Outcomes in Patients Without Previous Myocardial Infarction or Stroke: A Prespecified Analysis of the VESALIUS-CV Randomized Clinical Trial.
Journal: Circulation
Published: August 31, 2026
Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors.
Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors.
Journal: Thrombosis and haemostasis
Published: August 05, 2026
Incidence and Predictors of Extracranial Bleeding on Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation: A COMBINE-AF Analysis.
Journal: Circulation
Published: August 04, 2026
JCL Roundtable: Rewriting the rules for primary prevention: New outcomes from intensive LDL-C reduction in high-risk patients.
Journal: Journal of clinical lipidology
Published: July 31, 2026
Cumulative Benefit With Evolocumab in Patients With No Prior Myocardial Infarction or Stroke in the VESALIUS-CV Study.
Journal: Journal of the American College of Cardiology
Published: July 07, 2026
Evolocumab and risk of first myocardial infarction: the VESALIUS-CV trial.
Journal: European heart journal
Published: July 07, 2026
PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.
Journal: Journal of lipid research
Published: June 13, 2026
Patient-Centered Evaluation of Anticoagulation in Atrial Fibrillation.
Journal: NEJM evidence
Published: May 26, 2026
Evolocumab in Patients With Prior Percutaneous Coronary Intervention and No Prior Myocardial Infarction: Results From the VESALIUS-CV Trial.
Journal: Circulation
Published: May 19, 2026
Efficacy and safety of olezarsen in patients with vs without baseline fibrate use.
Journal: Journal of clinical lipidology
Published: May 13, 2026
Last Updated: 09/26/2026